Neurocardiogenic syncope tilt table testing

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Neurocardiogenic Syncope Microchapters

Home

Patient Info

Overview

Pathophysiology

Epidemiology and Demographics

Risk Factors

Causes

Natural History, Complications & Prognosis

Differentiating Neurocardiogenic Syncope From Other Diseases

Diagnosis

History & Symptoms

Physical Examination

Tilt Table Testing

Treatment

Pharmacotherapy

Pacemaker therapy

Neurocardiogenic syncope tilt table testing On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neurocardiogenic syncope tilt table testing

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neurocardiogenic syncope tilt table testing

CDC on Neurocardiogenic syncope tilt table testing

Neurocardiogenic syncope tilt table testing in the news

Blogs on Neurocardiogenic syncope tilt table testing

Directions to Hospitals Treating Neurocardiogenic Syncope

Risk calculators and risk factors for Neurocardiogenic syncope tilt table testing

Overview

The head-up tilt table test mimics the orthostatic stress. The orthostatic stress results in maximal venous pooling, central hypovolaemia and peripheral provocation of vasovagal syncope.

Role in diagnosis of Neurocardiogenic Shock

In-spite of the test being positive in patients with neurocardiogenic shock, it is not considered as a gold standard for diagnosis because of its limited sensitivity, specificity and reproducibility.

Depending on patient selection and protocol, the test has high sensitivity (upto 80%) but low specificity.